- Home
- MNSB vs OBIO Comparison
MNSB vs OBIO Comparison
Compare MNSB & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNSB
- OBIO
- Stock Information
- Founded
- MNSB 2003
- OBIO 2017
- Country
- MNSB United States
- OBIO United States
- Employees
- MNSB N/A
- OBIO N/A
- Industry
- MNSB Major Banks
- OBIO Medicinal Chemicals and Botanical Products
- Sector
- MNSB Finance
- OBIO Health Care
- Exchange
- MNSB Nasdaq
- OBIO Nasdaq
- Market Cap
- MNSB 170.1M
- OBIO 147.8M
- IPO Year
- MNSB N/A
- OBIO N/A
- Fundamental
- Price
- MNSB $21.14
- OBIO $2.50
- Analyst Decision
- MNSB
- OBIO Strong Buy
- Analyst Count
- MNSB 0
- OBIO 4
- Target Price
- MNSB N/A
- OBIO $14.00
- AVG Volume (30 Days)
- MNSB 22.0K
- OBIO 247.4K
- Earning Date
- MNSB 10-27-2025
- OBIO 11-11-2025
- Dividend Yield
- MNSB 1.89%
- OBIO N/A
- EPS Growth
- MNSB N/A
- OBIO N/A
- EPS
- MNSB N/A
- OBIO N/A
- Revenue
- MNSB $64,604,000.00
- OBIO $2,944,000.00
- Revenue This Year
- MNSB $23.19
- OBIO $29.26
- Revenue Next Year
- MNSB $2.92
- OBIO $10.65
- P/E Ratio
- MNSB N/A
- OBIO N/A
- Revenue Growth
- MNSB N/A
- OBIO 41.61
- 52 Week Low
- MNSB $15.00
- OBIO $2.37
- 52 Week High
- MNSB $22.98
- OBIO $6.50
- Technical
- Relative Strength Index (RSI)
- MNSB 42.05
- OBIO 40.73
- Support Level
- MNSB $20.88
- OBIO $2.45
- Resistance Level
- MNSB $21.86
- OBIO $2.68
- Average True Range (ATR)
- MNSB 0.37
- OBIO 0.11
- MACD
- MNSB -0.21
- OBIO -0.02
- Stochastic Oscillator
- MNSB 14.44
- OBIO 14.71
About MNSB MainStreet Bancshares Inc.
MainStreet Bancshares Inc is a bank holding company. It is focused on serving the borrowing, cash management and depository needs of small to medium-sized businesses, and professional practices and retail customers. The bank's products and services include business and consumer checking, premium interest-bearing checking, business account analysis, savings, certificates of deposit and other depository services, as well as a broad array of commercial, real estate and consumer loans.
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.